Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant FOLR1 (Mirvetuximab Biosimilar) antibody

Research Grade Reactivity: Human ELISA, WB Host: Human Chimeric unconjugated Recombinant Antibody
Catalog No. ABIN7538071
  • Target
    FOLR1 (Mirvetuximab Biosimilar)
    Antibody Type
    Recombinant Antibody
    Reactivity
    Human
    Host
    • 1
    Human
    Expression System
    Mammalian cells
    Clonality
    • 1
    Chimeric
    Conjugate
    • 1
    This FOLR1 (Mirvetuximab Biosimilar) antibody is un-conjugated
    Application
    ELISA, Western Blotting (WB)
    Purpose
    Mirvetuximab Biosimilar - Anti-FOLR1 mAb - Research Grade
    Characteristics
    Antibody Type: IgG1-kappa
    Purification
    Recombinant antibody expressed in mammalien cells and purified.
    Purity
    > 85%
    Grade
    Research Grade
    Isotype
    IgG1 kappa
  • Restrictions
    For Research Use only
  • Buffer
    PBS buffer PH7.5
    Storage
    -80 °C
    Storage Comment
    store at -80°C
  • Target
    FOLR1 (Mirvetuximab Biosimilar)
    Target Type
    Biosimilar
    Background
    Mirvetuximab is an anti-FOLR1 (folate receptor 1) monoclonal antibody. Mirvetuximab is the antibody moiety of novel folate receptor alpha (FRα)-targeting ADC (Mirvetuximab soravtansine). Mirvetuximab soravtansine can be used in ovarian and other FRα-positive cancer research.
    CAS-No
    1453084-36-0
You are here:
Support